3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Facial Injectables Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-3P7500
Home | Market Reports | Beauty & Fitness| Cosmetic Procedures
Global Facial Injectables Market Insights and Forecast to 2028
BUY CHAPTERS

Global Facial Injectables Market Research Report 2025

Code: QYRE-Auto-3P7500
Report
August 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Facial Injectables Market Size

The global market for Facial Injectables was valued at US$ 11490 million in the year 2024 and is projected to reach a revised size of US$ 20620 million by 2031, growing at a CAGR of 8.8% during the forecast period.

Facial Injectables Market

Facial Injectables Market

Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore collagen lost due to aging. Collagen and HA provide essential support to skin and help it retain its elasticity. The glabellar lines, wrinkles, and lines can be reduced with facial aesthetic treatment.
In terms of geographical regions, the Americas will be the major market contributor throughout the next few years. The US is the major revenue contributor in this region, where rapid advances in technology, the increasing awareness about aesthetic procedures, and the increasing demand for minimally invasive techniques, will bolster the market’s growth prospects.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Facial Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Facial Injectables.
The Facial Injectables market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Facial Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Facial Injectables manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Facial Injectables Market Report

Report Metric Details
Report Name Facial Injectables Market
Accounted market size in year US$ 11490 million
Forecasted market size in 2031 US$ 20620 million
CAGR 8.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Botox
  • Dermal Fillers
  • Other
Segment by Application
  • Hospitals
  • Clinics
  • Cosmetic Centers
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan, Merz Aesthetics, Prollenium Medical Technologies, Bloomega BioTechnology, Galderma, Ipsen Group, Suneva Medical, Polymekon, Visionmed, Syneron, Medytox, AQTIS Medical, ColBar LifeScience, SciVision Biotech, Hangzhou Techderm Biological Products, Qufu Guanglong Biochem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Facial Injectables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Facial Injectables in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Facial Injectables Market growing?

Ans: The Facial Injectables Market witnessing a CAGR of 8.8% during the forecast period 2025-2031.

What is the Facial Injectables Market size in 2031?

Ans: The Facial Injectables Market size in 2031 will be US$ 20620 million.

Who are the main players in the Facial Injectables Market report?

Ans: The main players in the Facial Injectables Market are Allergan, Merz Aesthetics, Prollenium Medical Technologies, Bloomega BioTechnology, Galderma, Ipsen Group, Suneva Medical, Polymekon, Visionmed, Syneron, Medytox, AQTIS Medical, ColBar LifeScience, SciVision Biotech, Hangzhou Techderm Biological Products, Qufu Guanglong Biochem

What are the Application segmentation covered in the Facial Injectables Market report?

Ans: The Applications covered in the Facial Injectables Market report are Hospitals, Clinics, Cosmetic Centers, Other

What are the Type segmentation covered in the Facial Injectables Market report?

Ans: The Types covered in the Facial Injectables Market report are Botox, Dermal Fillers, Other

1 Facial Injectables Market Overview
1.1 Product Definition
1.2 Facial Injectables by Type
1.2.1 Global Facial Injectables Market Value Comparison by Type (2024 VS 2031)
1.2.2 Botox
1.2.3 Dermal Fillers
1.2.4 Other
1.3 Facial Injectables by Application
1.3.1 Global Facial Injectables Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cosmetic Centers
1.3.5 Other
1.4 Global Facial Injectables Market Size Estimates and Forecasts
1.4.1 Global Facial Injectables Revenue 2020-2031
1.4.2 Global Facial Injectables Sales 2020-2031
1.4.3 Global Facial Injectables Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Facial Injectables Market Competition by Manufacturers
2.1 Global Facial Injectables Sales Market Share by Manufacturers (2020-2025)
2.2 Global Facial Injectables Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Facial Injectables Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Facial Injectables, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Facial Injectables, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Facial Injectables, Product Type & Application
2.7 Global Key Manufacturers of Facial Injectables, Date of Enter into This Industry
2.8 Global Facial Injectables Market Competitive Situation and Trends
2.8.1 Global Facial Injectables Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Facial Injectables Players Market Share by Revenue
2.8.3 Global Facial Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Facial Injectables Market Scenario by Region
3.1 Global Facial Injectables Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Facial Injectables Sales by Region: 2020-2031
3.2.1 Global Facial Injectables Sales by Region: 2020-2025
3.2.2 Global Facial Injectables Sales by Region: 2026-2031
3.3 Global Facial Injectables Revenue by Region: 2020-2031
3.3.1 Global Facial Injectables Revenue by Region: 2020-2025
3.3.2 Global Facial Injectables Revenue by Region: 2026-2031
3.4 North America Facial Injectables Market Facts & Figures by Country
3.4.1 North America Facial Injectables Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Facial Injectables Sales by Country (2020-2031)
3.4.3 North America Facial Injectables Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Facial Injectables Market Facts & Figures by Country
3.5.1 Europe Facial Injectables Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Facial Injectables Sales by Country (2020-2031)
3.5.3 Europe Facial Injectables Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Facial Injectables Market Facts & Figures by Region
3.6.1 Asia Pacific Facial Injectables Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Facial Injectables Sales by Region (2020-2031)
3.6.3 Asia Pacific Facial Injectables Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Facial Injectables Market Facts & Figures by Country
3.7.1 Latin America Facial Injectables Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Facial Injectables Sales by Country (2020-2031)
3.7.3 Latin America Facial Injectables Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Facial Injectables Market Facts & Figures by Country
3.8.1 Middle East and Africa Facial Injectables Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Facial Injectables Sales by Country (2020-2031)
3.8.3 Middle East and Africa Facial Injectables Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Facial Injectables Sales by Type (2020-2031)
4.1.1 Global Facial Injectables Sales by Type (2020-2025)
4.1.2 Global Facial Injectables Sales by Type (2026-2031)
4.1.3 Global Facial Injectables Sales Market Share by Type (2020-2031)
4.2 Global Facial Injectables Revenue by Type (2020-2031)
4.2.1 Global Facial Injectables Revenue by Type (2020-2025)
4.2.2 Global Facial Injectables Revenue by Type (2026-2031)
4.2.3 Global Facial Injectables Revenue Market Share by Type (2020-2031)
4.3 Global Facial Injectables Price by Type (2020-2031)
5 Segment by Application
5.1 Global Facial Injectables Sales by Application (2020-2031)
5.1.1 Global Facial Injectables Sales by Application (2020-2025)
5.1.2 Global Facial Injectables Sales by Application (2026-2031)
5.1.3 Global Facial Injectables Sales Market Share by Application (2020-2031)
5.2 Global Facial Injectables Revenue by Application (2020-2031)
5.2.1 Global Facial Injectables Revenue by Application (2020-2025)
5.2.2 Global Facial Injectables Revenue by Application (2026-2031)
5.2.3 Global Facial Injectables Revenue Market Share by Application (2020-2031)
5.3 Global Facial Injectables Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Company Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan Facial Injectables Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Merz Aesthetics
6.2.1 Merz Aesthetics Company Information
6.2.2 Merz Aesthetics Description and Business Overview
6.2.3 Merz Aesthetics Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merz Aesthetics Facial Injectables Product Portfolio
6.2.5 Merz Aesthetics Recent Developments/Updates
6.3 Prollenium Medical Technologies
6.3.1 Prollenium Medical Technologies Company Information
6.3.2 Prollenium Medical Technologies Description and Business Overview
6.3.3 Prollenium Medical Technologies Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Prollenium Medical Technologies Facial Injectables Product Portfolio
6.3.5 Prollenium Medical Technologies Recent Developments/Updates
6.4 Bloomega BioTechnology
6.4.1 Bloomega BioTechnology Company Information
6.4.2 Bloomega BioTechnology Description and Business Overview
6.4.3 Bloomega BioTechnology Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bloomega BioTechnology Facial Injectables Product Portfolio
6.4.5 Bloomega BioTechnology Recent Developments/Updates
6.5 Galderma
6.5.1 Galderma Company Information
6.5.2 Galderma Description and Business Overview
6.5.3 Galderma Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Galderma Facial Injectables Product Portfolio
6.5.5 Galderma Recent Developments/Updates
6.6 Ipsen Group
6.6.1 Ipsen Group Company Information
6.6.2 Ipsen Group Description and Business Overview
6.6.3 Ipsen Group Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ipsen Group Facial Injectables Product Portfolio
6.6.5 Ipsen Group Recent Developments/Updates
6.7 Suneva Medical
6.7.1 Suneva Medical Company Information
6.7.2 Suneva Medical Description and Business Overview
6.7.3 Suneva Medical Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Suneva Medical Facial Injectables Product Portfolio
6.7.5 Suneva Medical Recent Developments/Updates
6.8 Polymekon
6.8.1 Polymekon Company Information
6.8.2 Polymekon Description and Business Overview
6.8.3 Polymekon Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Polymekon Facial Injectables Product Portfolio
6.8.5 Polymekon Recent Developments/Updates
6.9 Visionmed
6.9.1 Visionmed Company Information
6.9.2 Visionmed Description and Business Overview
6.9.3 Visionmed Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Visionmed Facial Injectables Product Portfolio
6.9.5 Visionmed Recent Developments/Updates
6.10 Syneron
6.10.1 Syneron Company Information
6.10.2 Syneron Description and Business Overview
6.10.3 Syneron Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Syneron Facial Injectables Product Portfolio
6.10.5 Syneron Recent Developments/Updates
6.11 Medytox
6.11.1 Medytox Company Information
6.11.2 Medytox Description and Business Overview
6.11.3 Medytox Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Medytox Facial Injectables Product Portfolio
6.11.5 Medytox Recent Developments/Updates
6.12 AQTIS Medical
6.12.1 AQTIS Medical Company Information
6.12.2 AQTIS Medical Description and Business Overview
6.12.3 AQTIS Medical Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.12.4 AQTIS Medical Facial Injectables Product Portfolio
6.12.5 AQTIS Medical Recent Developments/Updates
6.13 ColBar LifeScience
6.13.1 ColBar LifeScience Company Information
6.13.2 ColBar LifeScience Description and Business Overview
6.13.3 ColBar LifeScience Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.13.4 ColBar LifeScience Facial Injectables Product Portfolio
6.13.5 ColBar LifeScience Recent Developments/Updates
6.14 SciVision Biotech
6.14.1 SciVision Biotech Company Information
6.14.2 SciVision Biotech Description and Business Overview
6.14.3 SciVision Biotech Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.14.4 SciVision Biotech Facial Injectables Product Portfolio
6.14.5 SciVision Biotech Recent Developments/Updates
6.15 Hangzhou Techderm Biological Products
6.15.1 Hangzhou Techderm Biological Products Company Information
6.15.2 Hangzhou Techderm Biological Products Description and Business Overview
6.15.3 Hangzhou Techderm Biological Products Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hangzhou Techderm Biological Products Facial Injectables Product Portfolio
6.15.5 Hangzhou Techderm Biological Products Recent Developments/Updates
6.16 Qufu Guanglong Biochem
6.16.1 Qufu Guanglong Biochem Company Information
6.16.2 Qufu Guanglong Biochem Description and Business Overview
6.16.3 Qufu Guanglong Biochem Facial Injectables Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Qufu Guanglong Biochem Facial Injectables Product Portfolio
6.16.5 Qufu Guanglong Biochem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Facial Injectables Industry Chain Analysis
7.2 Facial Injectables Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Facial Injectables Production Mode & Process Analysis
7.4 Facial Injectables Sales and Marketing
7.4.1 Facial Injectables Sales Channels
7.4.2 Facial Injectables Distributors
7.5 Facial Injectables Customer Analysis
8 Facial Injectables Market Dynamics
8.1 Facial Injectables Industry Trends
8.2 Facial Injectables Market Drivers
8.3 Facial Injectables Market Challenges
8.4 Facial Injectables Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Facial Injectables Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Facial Injectables Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Facial Injectables Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Facial Injectables Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Facial Injectables Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Facial Injectables Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Facial Injectables Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Facial Injectables Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Facial Injectables, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Facial Injectables, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Facial Injectables, Product Type & Application
 Table 12. Global Key Manufacturers of Facial Injectables, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Facial Injectables by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Facial Injectables as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Facial Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Facial Injectables Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Facial Injectables Sales Market Share by Region (2020-2025)
 Table 19. Global Facial Injectables Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Facial Injectables Sales Market Share by Region (2026-2031)
 Table 21. Global Facial Injectables Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Facial Injectables Revenue Market Share by Region (2020-2025)
 Table 23. Global Facial Injectables Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Facial Injectables Revenue Market Share by Region (2026-2031)
 Table 25. North America Facial Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Facial Injectables Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Facial Injectables Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Facial Injectables Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Facial Injectables Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Facial Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Facial Injectables Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Facial Injectables Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Facial Injectables Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Facial Injectables Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Facial Injectables Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Facial Injectables Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Facial Injectables Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Facial Injectables Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Facial Injectables Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Facial Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Facial Injectables Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Facial Injectables Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Facial Injectables Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Facial Injectables Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Facial Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Facial Injectables Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Facial Injectables Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Facial Injectables Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Facial Injectables Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Facial Injectables Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Facial Injectables Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Facial Injectables Sales Market Share by Type (2020-2025)
 Table 53. Global Facial Injectables Sales Market Share by Type (2026-2031)
 Table 54. Global Facial Injectables Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Facial Injectables Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Facial Injectables Revenue Market Share by Type (2020-2025)
 Table 57. Global Facial Injectables Revenue Market Share by Type (2026-2031)
 Table 58. Global Facial Injectables Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Facial Injectables Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Facial Injectables Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Facial Injectables Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Facial Injectables Sales Market Share by Application (2020-2025)
 Table 63. Global Facial Injectables Sales Market Share by Application (2026-2031)
 Table 64. Global Facial Injectables Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Facial Injectables Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Facial Injectables Revenue Market Share by Application (2020-2025)
 Table 67. Global Facial Injectables Revenue Market Share by Application (2026-2031)
 Table 68. Global Facial Injectables Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Facial Injectables Price (USD/Pcs) by Application (2026-2031)
 Table 70. Allergan Company Information
 Table 71. Allergan Description and Business Overview
 Table 72. Allergan Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Allergan Facial Injectables Product
 Table 74. Allergan Recent Developments/Updates
 Table 75. Merz Aesthetics Company Information
 Table 76. Merz Aesthetics Description and Business Overview
 Table 77. Merz Aesthetics Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Merz Aesthetics Facial Injectables Product
 Table 79. Merz Aesthetics Recent Developments/Updates
 Table 80. Prollenium Medical Technologies Company Information
 Table 81. Prollenium Medical Technologies Description and Business Overview
 Table 82. Prollenium Medical Technologies Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Prollenium Medical Technologies Facial Injectables Product
 Table 84. Prollenium Medical Technologies Recent Developments/Updates
 Table 85. Bloomega BioTechnology Company Information
 Table 86. Bloomega BioTechnology Description and Business Overview
 Table 87. Bloomega BioTechnology Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Bloomega BioTechnology Facial Injectables Product
 Table 89. Bloomega BioTechnology Recent Developments/Updates
 Table 90. Galderma Company Information
 Table 91. Galderma Description and Business Overview
 Table 92. Galderma Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Galderma Facial Injectables Product
 Table 94. Galderma Recent Developments/Updates
 Table 95. Ipsen Group Company Information
 Table 96. Ipsen Group Description and Business Overview
 Table 97. Ipsen Group Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Ipsen Group Facial Injectables Product
 Table 99. Ipsen Group Recent Developments/Updates
 Table 100. Suneva Medical Company Information
 Table 101. Suneva Medical Description and Business Overview
 Table 102. Suneva Medical Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Suneva Medical Facial Injectables Product
 Table 104. Suneva Medical Recent Developments/Updates
 Table 105. Polymekon Company Information
 Table 106. Polymekon Description and Business Overview
 Table 107. Polymekon Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Polymekon Facial Injectables Product
 Table 109. Polymekon Recent Developments/Updates
 Table 110. Visionmed Company Information
 Table 111. Visionmed Description and Business Overview
 Table 112. Visionmed Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Visionmed Facial Injectables Product
 Table 114. Visionmed Recent Developments/Updates
 Table 115. Syneron Company Information
 Table 116. Syneron Description and Business Overview
 Table 117. Syneron Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Syneron Facial Injectables Product
 Table 119. Syneron Recent Developments/Updates
 Table 120. Medytox Company Information
 Table 121. Medytox Description and Business Overview
 Table 122. Medytox Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Medytox Facial Injectables Product
 Table 124. Medytox Recent Developments/Updates
 Table 125. AQTIS Medical Company Information
 Table 126. AQTIS Medical Description and Business Overview
 Table 127. AQTIS Medical Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. AQTIS Medical Facial Injectables Product
 Table 129. AQTIS Medical Recent Developments/Updates
 Table 130. ColBar LifeScience Company Information
 Table 131. ColBar LifeScience Description and Business Overview
 Table 132. ColBar LifeScience Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. ColBar LifeScience Facial Injectables Product
 Table 134. ColBar LifeScience Recent Developments/Updates
 Table 135. SciVision Biotech Company Information
 Table 136. SciVision Biotech Description and Business Overview
 Table 137. SciVision Biotech Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. SciVision Biotech Facial Injectables Product
 Table 139. SciVision Biotech Recent Developments/Updates
 Table 140. Hangzhou Techderm Biological Products Company Information
 Table 141. Hangzhou Techderm Biological Products Description and Business Overview
 Table 142. Hangzhou Techderm Biological Products Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. Hangzhou Techderm Biological Products Facial Injectables Product
 Table 144. Hangzhou Techderm Biological Products Recent Developments/Updates
 Table 145. Qufu Guanglong Biochem Company Information
 Table 146. Qufu Guanglong Biochem Description and Business Overview
 Table 147. Qufu Guanglong Biochem Facial Injectables Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 148. Qufu Guanglong Biochem Facial Injectables Product
 Table 149. Qufu Guanglong Biochem Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Facial Injectables Distributors List
 Table 153. Facial Injectables Customers List
 Table 154. Facial Injectables Market Trends
 Table 155. Facial Injectables Market Drivers
 Table 156. Facial Injectables Market Challenges
 Table 157. Facial Injectables Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Facial Injectables
 Figure 2. Global Facial Injectables Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Facial Injectables Market Share by Type: 2024 & 2031
 Figure 4. Botox Product Picture
 Figure 5. Dermal Fillers Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Facial Injectables Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Facial Injectables Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Clinics
 Figure 11. Cosmetic Centers
 Figure 12. Other
 Figure 13. Global Facial Injectables Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Facial Injectables Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Facial Injectables Sales (2020-2031) & (K Pcs)
 Figure 16. Global Facial Injectables Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Facial Injectables Report Years Considered
 Figure 18. Facial Injectables Sales Share by Manufacturers in 2024
 Figure 19. Global Facial Injectables Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Facial Injectables Players: Market Share by Revenue in Facial Injectables in 2024
 Figure 21. Facial Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Facial Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Facial Injectables Sales Market Share by Country (2020-2031)
 Figure 24. North America Facial Injectables Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Facial Injectables Sales Market Share by Country (2020-2031)
 Figure 28. Europe Facial Injectables Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Facial Injectables Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Facial Injectables Revenue Market Share by Region (2020-2031)
 Figure 36. China Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Facial Injectables Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Facial Injectables Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Facial Injectables Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Facial Injectables Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Facial Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Facial Injectables by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Facial Injectables by Type (2020-2031)
 Figure 58. Global Facial Injectables Price (USD/Pcs) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Facial Injectables by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Facial Injectables by Application (2020-2031)
 Figure 61. Global Facial Injectables Price (USD/Pcs) by Application (2020-2031)
 Figure 62. Facial Injectables Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS